Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Request a FREE Sample of our FcRn Binding Kit!
Request a FREE Sample of our Fc gamma RI / CD64 Binding Kit !
Happy Holiday! Limited Keychain here with your next orderHappy Holiday! Limited Keychain here with your next order
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
A-Z
> Exhibition > Challenges and Strategies in Method Development for Vaccine Efficacy Evaluation 
Wenlin Ren, Ph.D.
Associate Product Director of ACROBiosystems
Topic:
Challenges and Strategies in Method Development for Vaccine Efficacy Evaluation
In the long-term struggle against the virus, vaccine is one of the important ways to prevent and control the spread of the disease. The evaluation of vaccine safety, efficacy, as well as production quality control are crucial to the success of vaccine research and development. In the process of developing methods for vaccine efficacy evaluation, the choice of core components is crucial, as they directly impact the success of the methodology. This webinar will dive into real-world cases and discuss strategies for addressing challenges in method development for vaccine efficacy evaluation
- Target Proteins Considerations in Vaccine Development: We will discuss the specific requirements for recombinant proteins used in the vaccine development and the underlying design principles guiding their selection.
- Development strategy and Case Studies of High-Quality Recombinant Proteins: Using practical examples, we will showcase our standards for research, development, and quality control of vaccine-related recombinant protein products.
- Methodology Development in Vaccine Evaluation: Case Study: Finally, we will share practical cases highlighting key aspects of method development in vaccine efficacy evaluation.
ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. We supply life science tools designed to be used in discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, we deliver solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. We empower scientists and engineers dedicated towards innovation to simplify and accelerate the development of new, better, and more affordable medicine.
This web search service is supported by Google Inc.
